Official Title: “Comparison of CL Wear Between Epinastine Hydrochloride and Olopatadine Hydrochloride”

Comparison of two allergy drops for enhancing comfort and performance of contact lens wear

Study Type: Interventional

Study Design: Treatment, Randomized, Single Blind, Active Control, Crossover Assignment, Efficacy Study

Contact lens patients will instill allergy drops and subjective and objective tests will be performed

Intervention(s) in this Clinical Trial

• Drug: epinastine HCL and olopatadine HCL

Primary Measures

• Contact lens objective and subjective clinical performance testing
  • Time Frame: up to 3 months
    

Inclusion Criteria:

• Males or females > 18 years old
• Mild to moderate dry eye symptoms
• Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

• Current use of topical cyclosporine
• Known contraindications to any study medication or ingredients
• Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
• Ocular surgery within the past 3 months

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers

Lead Sponsor: Hom, Milton M., OD, FAAO

Overall Clinical Trial Officials and Contacts

Milton M Hom, OD FAAO Study Director Private Practice  

Overall Contact: Milton M Hom, OD FAAO 6269637100 eyemage@mminternet.com

Information obtained from ClinicalTrials.gov on November 20, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00489398

Study ID Number: 5316

ClinicalTrials.gov Identifier: NCT00489398

Health Authority: United States: Institutional Review Board